Symbol: |
OSGIN1
|
Description: |
oxidative stress induced growth inhibitor 1 [Source:HGNC Symbol;Acc:30093]
|
Location: |
Chr16:83981887-83999937[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:273
Gene |
Compound |
Gen_sig |
Exp_pattern |
OSGIN1 |
2-Naphthacenecarboxamide, N-[(6,7-dihydro-7-oxo-v-triazolo[4,5-d]pyrimidin-5-ylamino)methyl]-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo- |
0.022 |
Up |
OSGIN1 |
rac-2-Methyleneoxy-1-O-octyl-myo-inistol |
0.001 |
Up |
OSGIN1 |
NSC 676762 |
0.003 |
Up |
OSGIN1 |
NSC 676855 |
0.014 |
Up |
OSGIN1 |
Uracil, 3-methyl-6-(phenylhydrazino)- |
0.049 |
Up |
OSGIN1 |
7H-Pyrrolo[2,3-d]pyrimidine, 5,6-dimethyl- 2,4-bis(methylsulfinyl)-7-phenyl- |
0.038 |
Up |
OSGIN1 |
NSC 677807 |
0.027 |
Down |
OSGIN1 |
Methanone, (tricyclo[3.3.1.1(3,7)]decan-1-yl) [3-(3-nitrophenyl)-2-oxiranyl]- |
0.002 |
Up |
OSGIN1 |
Benzoic acid, 2-[(4,6-dimethyl-1-oxo-2-indanylidene) methyl]-5-methyl-, methyl ester |
0.027 |
Up |
OSGIN1 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- |
0.003 |
Up |
OSGIN1 |
Thymine, 1-[1,2-bis(ethoxycarbonyl)ethenyl]- |
0.004 |
Up |
OSGIN1 |
Adenine, 9-[1,2-bis(ethoxycarbonyl)ethenyl]-, trans- |
0.014 |
Up |
OSGIN1 |
Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-3-[(ethoxy-carbonyl)methyl]-, trans- |
0.004 |
Up |
OSGIN1 |
NSC 679073 |
0.005 |
Up |
OSGIN1 |
NSC 679509 |
0.005 |
Up |
Expression pattern: Sensitivity / Resistance
Total:19 Current:9
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:9
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:63
Total:5 Current:1
[First] [Prev]  Next Last 
|